209 related articles for article (PubMed ID: 29215001)
1. Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling.
Park-Windhol C; Ng YS; Yang J; Primo V; Saint-Geniez M; D'Amore PA
Sci Rep; 2017 Dec; 7(1):17138. PubMed ID: 29215001
[TBL] [Abstract][Full Text] [Related]
2. Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity.
LeBlanc ME; Saez-Torres KL; Cano I; Hu Z; Saint-Geniez M; Ng YS; D'Amore PA
FASEB J; 2019 Aug; 33(8):9362-9373. PubMed ID: 31141406
[TBL] [Abstract][Full Text] [Related]
3. Endomucin selectively regulates vascular endothelial growth factor receptor-2 endocytosis through its interaction with AP2.
Cano I; Wild M; Gupta U; Chaudhary S; Ng YSE; Saint-Geniez M; D'Amore PA; Hu Z
Cell Commun Signal; 2024 Apr; 22(1):225. PubMed ID: 38605348
[TBL] [Abstract][Full Text] [Related]
4. Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity.
Hu Z; Cano I; Saez-Torres KL; LeBlanc ME; Saint-Geniez M; Ng YS; Argüeso P; D'Amore PA
Cells; 2020 Jun; 9(6):. PubMed ID: 32517158
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
6. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
7. Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.
Kanugula AK; Adapala RK; Midha P; Cappelli HC; Meszaros JG; Paruchuri S; Chilian WM; Thodeti CK
FASEB J; 2019 Jan; 33(1):195-203. PubMed ID: 29957061
[TBL] [Abstract][Full Text] [Related]
8. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
[TBL] [Abstract][Full Text] [Related]
9. Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition.
Yadav UC; Srivastava SK; Ramana KV
J Diabetes Complications; 2012; 26(5):369-77. PubMed ID: 22658411
[TBL] [Abstract][Full Text] [Related]
10. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
[TBL] [Abstract][Full Text] [Related]
11. Retinal pigment epithelium-derived transforming growth factor-β2 inhibits the angiogenic response of endothelial cells by decreasing vascular endothelial growth factor receptor-2 expression.
Jeong HS; Yun JH; Lee DH; Lee EH; Cho CH
J Cell Physiol; 2019 Apr; 234(4):3837-3849. PubMed ID: 30256387
[TBL] [Abstract][Full Text] [Related]
12. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
[TBL] [Abstract][Full Text] [Related]
13. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Pang X; Yi Z; Zhang X; Sung B; Qu W; Lian X; Aggarwal BB; Liu M
Cancer Res; 2009 Jul; 69(14):5893-900. PubMed ID: 19567671
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer.
Chen HY; Zhou ZY; Luo YL; Luo Q; Fan JT
Cell Biol Int; 2021 Dec; 45(12):2557-2566. PubMed ID: 34498339
[TBL] [Abstract][Full Text] [Related]
17. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
18. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
[TBL] [Abstract][Full Text] [Related]
19. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Hartnett ME
Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
[TBL] [Abstract][Full Text] [Related]
20. β₂-glycoprotein I inhibits VEGF-induced endothelial cell growth and migration via suppressing phosphorylation of VEGFR2, ERK1/2, and Akt.
Chiu WC; Lin JY; Lee TS; You LR; Chiang AN
Mol Cell Biochem; 2013 Jan; 372(1-2):9-15. PubMed ID: 22956423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
